People with diabetes can now get an early warning when a dangerous complication starts to build in their bodies.

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.

FDA approves Abbott's Libre Duo 10 Day, the first wearable to continuously monitor ketone and glucose levels for diabetes patients.